Categories
Tags
Abbott Advertising AstraZeneca Barack Obama Biotechnology and Pharmaceuticals Breast cancer Bristol Myers Squibb business Cancer Clinical trial Conditions and Diseases Deal Eli Lilly European Commission European Union FDA Food and Drug Administration Genentech generics GlaxoSmithKline Google GSK HBA Health Health care Johnson & Johnson layoffs Lilly Margaret Hamburg Marketing Merck Novartis Pfizer Pharma Pharmaceutical drug pharmaceutical industry Research and development Roche Sanofi-Aventis Schering Plough social media Twitter U.S. Food and Drug Administration United States Wyeth
Technology News
BioPharm News- Shire Gains European Approval for its Gaucher Disease Treatment
- Mtech Bioprocess Scale-Up Facility to Double in Staff and Size
- ImClone Closes Plant in New Jersey, Consolidating Erbitux Manufacture
- EMA and FDA Seek Applicants for Joint GMP Inspections
- ATMI Expands Bloomington, Minnesota Manufacturing Facility
Clinical Trials News- CRF Health Achieves EXACT ePRO Vendor Certification for Windows Mobile Systems
- ACR Image Metrix Establishes Global Presence
- BioPharm Systems Named to the 2010 Inc. 500|5000 List of Fastest-Growing Companies in the U.S.
- CRF Health Doubles North American Headquarters
- Oracle Completes Acquisition of Phase Forward
Blogroll
-
Meta
Tag Archives: generics
WHO Threatens Industry Shut-out on Counterfeit Regulation
Big Pharma believes that a global generics franchise might give it a softer landing off the patent cliff, but governments that sponsor and regulate the industry are still acting a bit slow on the uptake. The reason? Anti-IP activists are again poisoning the well on global access to medicines, engaging the bigger emerging market governments [...]
Posted in Global Also tagged Brazil, IFPMA, india, WHO, World Health Assembly, World Health Organization Leave a comment
Authorized Generics Agreements to Increase
Image by :: Wendy :: via Flickr
The number of authorized generics (AG) agreements is likely to grow as pharma continues to converge with generics companies, a new report from Datamonitor claims. AG agreements are considered more ‘potent’ in the US market because market exclusivity is awarded to first-to-file generics companies, but detractors among the generics-producing [...]
Posted in Global, News, Regulatory Also tagged analysis, branded pharma, Datamonitor, patents, Pharmaceuticals, Regulatory 1 Comment
The EC Admonishes European Pharma, European Pharma Celebrates
Despite the rhetoric, the climax of the European Commission’s antitrust investigations — instigated with dawn raids on the major pharma companies by EC Competition Commissioner Neelie Kroes last year — has been more of a whimper than a bang.
Pharm Exec Europe’s EU correspondent Reflector goes so far as to say “Big Pharma is not opening [...]
Posted in Global, Regulatory Also tagged anti-competitive, antitrust, Brussels, EC, European Commission, European Union, investigations, Neelie Kroes, Regulatory Leave a comment

Abbott Shells Out $3.7 Billion for Piramal